z-logo
open-access-imgOpen Access
Anti‐programmed death ligand 1 therapy‐induced type 1 diabetes presenting with multiple islet‐related autoantibodies
Author(s) -
Honoki Hisae,
Yagi Kunimasa,
Kambara Kenta,
Chujo Daisuke,
Shikata Masataka,
Enkaku Asako,
TakikawaNishida Akiko,
Liu Jianhui,
Fujisaka Shiho,
Tobe Kazuyuki
Publication year - 2020
Publication title -
journal of diabetes investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.089
H-Index - 50
eISSN - 2040-1124
pISSN - 2040-1116
DOI - 10.1111/jdi.13099
Subject(s) - medicine , atezolizumab , autoantibody , type 1 diabetes , type 2 diabetes , lung cancer , gastroenterology , cancer , nivolumab , diabetes mellitus , immunology , antibody , endocrinology , immunotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here